Polypharmacy and Deprescribing in Older Adults
|
|
- Marcus Webb
- 5 years ago
- Views:
Transcription
1 MEDICARE CARE DELIVERY Polypharmacy and Deprescribing in Older Adults Oregon Geriatrics Society October 9, 2016 Arthur Hayward, MD, MBA Internist and Geriatrician, Kaiser Permanente Northwest Session Objectives 1. Identify examples of polypharmacy 2. Recognize the particular risks of polypharmacy in the elderly 3. Apply deprescribing algorithms 2 October 10,
2 Case Histories yo on opioids for chronic pancreatitis reports his wife died unexpectedly yo retired math teacher with dementia has become a zombie after entering a nursing home yo diabetic in ED for falls has HGBA1C of 6%. 4. Wife says her 79 yo mate won t take all his medicines. 3 October 10, 2016 MEDICARE CARE DELIVERY Man has an inborn craving for medicine. Heroic dosing for several generations has given his tissues a thirst for drugs. The desire to take medicine is one feature which distinguishes man, the animal, from his fellow creatures. William Osler,
3 Brief History of Polypharmacy Drugs perform miracles Drugs are widely prescribed Drugs are too widely prescribed Harms result Deprescribing reduces polypharmacy 5 October 10, 2016 Outline 1. Signs of polypharmacy 2. Altered risk/benefit in older adults 3. Solution: Deprescribe? 4. Signs of the deprescribing era 5. Benefits of deprescribing 6 October 10,
4 1. Signs of polypharmacy Reflex prescribing Pharmaceutical hype Increased volume, costs, ADEs Backlash 7 October 10, 2016 Reflex Prescribing Failure to consider alternatives Misapplying guidelines Mistaking ADEs for new conditions Huseyin Naci, John P A Ioannidis. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ 2013; 347 doi: 8 October 10,
5 Non-pharma treatment alternatives For A. Not B. But Back pain NSAIDs Cold and hot compresses Insomnia Zolpidem Sleep hygiene Urinary urgency Ditropan Pelvic floor exercises Depression SSRI s Cognitive behavioral Rx Dementia behaviors Antipsychotics Environmental change Anxiety Benzo s Stress reduction activity Adapted from KP Colorado Clinical Practice Guideline Polypharmacy in the Elderly Statin use in adults older than 79 August 24, doi: /jamainternmed October 10,
6 The Drug Cascade A vicious Drug-ADE Cycle Start here Hip pain Hip fracture Fall Ibuprofen HTN Orthostasis HCTZ Terazosin Oxybutynin Urinary Retention Rochon P, GurwitzJ. Optimising drug treatment for elderly people: the prescribing cascade. BMJ, 1997; 315:
7 Pharmaceutical hype Product promotion Choice of product Narcotic epidemic Who is responsible for the pain pill epidemic? in The New Yorker 11/8/ October 10, 2016 Inducements 14 October 10, 2011 Kaiser Foundation Health Plan, 7
8 From: Pharmaceutical Industry Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries Target branded drugs as a percentage of all filled prescriptions in the drug class. JAMA Intern Med. 2016;176(8): doi: /jamainternmed Date of download: 8/2/2016 Copyright 2016 American Medical Association. All rights reserved. Opioid (over)use 16 October 10,
9 Narcotic drugs more lethal than autos New York Times, December 18, 2015 Pharma Promotion of Opioid Use Opioids have been aggressively and misleadingly marketed to physicians 1 Federal bodies and state medical boards received funds to promote pain relief 2 Experts with pharma connections have rallied to criticize CDC proposed guidelines 3 1 Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 2009;99: Who is responsible for the pain pill epidemic? in The New Yorker 11/8/ AP wire services 1/31/2016 report on Interagency Pain Research Coordinating Committee 18 October 10,
10 CDC assessment of opioid use Deaths from prescription drug overdose have quadrupled since Opioids can worsen pain and functioning. Risks increase with dose increases. Use of heroin and illicitly produced Fentanyl has increased. CDC recommends non-pharmacologic approaches. CDC Guideline with comment NEJM March 15, 2016 DOI: /NEJMp CDC guideline for prescribing opioids for chronic pain United States, MMWR Recomm Rep 2016;65(RR-1: October 10, 2016 Volume Increased numbers of prescriptions (4 B/y) Increased ADEs Increased drug costs ($259B) ($329.1B) IMS Health Inc. data cited by Henry Kaiser Family Foundation Drugmakers article. Wall Street Journal. Oct 3, October 10,
11 % of US adults reporting use of any and of > 5 drugs per day during preceding 30 days by age NHANES data reported by Kantor, E, et al. JAMA November 3, 2015 Volume 314, Number October 10, 2011 Kaiser Foundation Health Plan, National Social Life, Health and Aging Project Changes in Use of Drugs, OTCs, and Supplements 2005 to 2011 Findings: Use of any med % Use of >/= 5 meds % Use of dietary supplements % Risk of potential major drug-drug interaction % Data from the National Social Life, Health and Aging Project. College of Pharmacy, U of Chicago. JAMA Intern Med. doi: /jamainternmed Published online March 21, October 10, 2011 Kaiser Foundation Health Plan, 11
12 10/10/2016 Robin Hood Profiteering The New Yorker January 4, 2016 How does epinephrine become a $1B drug? Sunday Business Section New York Times September 4, 2016 Heather Bresch, Chief Executive, Mylan Pharmaceuticals 24 October 10, Kaiser Foundation Health Plan, Inc. For internal use only. 12
13 The Other Drug Problem The Oregonian LIVING HEALTH Friday, Sept. 9, October 10, 2016 Signs of polypharmacy Consumer mistrust and backlash 26 October 10,
14 2. Risk/Benefit increases in adults >/= 65 Changes in metabolism and pharmacokinetics/dynamics More conditions/ more guidelines/ more prescribers More side effects 1 / drug cascade to treat side effects Less time to benefit Expense of polypharmacy (estimated ~ $50B/y in US) 2 Multiple meds: inconvenience, burden, misery 1. Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;10:CD CMMS estimate cited in Lyles A, Culver N, Ivester J, Potter T. effects of health literacy and polypharmacy on medication adherence. Consult Pharm. 2013;28: October 10, Solution: Deprescribe? Deprescribingis the process of tapering or stopping drugs, aimed at minimizing polypharmacyand improving patient outcomes. 1 Pharmacists play a leading role. Deprescribing algorithms exist 1,2,3 --Ian Scott, et al, Brisbane, Australia 1. JAMA Intern Med. doi: /jamainternmed Published online March 23, Garfinkle. Arch Intern Med. 2010;170(18): Frankenthal, et al. (STOPP/START) J Am Geriatr Soc 62: , October 10,
15 Barriers to Deprescribing Survey results of PCPs: Lack of knowledge (39% not aware tight glucose control harms older adults) Fear of bad report card (42%) Fear of legal liability (25%) Not enough time to discuss (30%) JAMA Intern Med. 2015;175(12): doi: /jamainternmed LESS IS MORE Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults Garfinkel D, Mangin D Arch Intern Med. 2010;170(18): Protocol- indicated stop of 311 meds in 64 of 70 patients included Result Failure (re-started for original indication) 2% Success (consented and not re-started) 81% Compared to matched cohort Global improvement in health 88% Mortality benefit 14% 15
16 Improving drug therapy in elderly patients--the Good Palliative-Geriatric Practice algorithm Garfinkel D, Mangin D. Arch Intern Med 2010;170: October 10, 2016 Deprescribing simplified 1. Stop Drugs that are unnecessary Duplicates 2. Shift Safer for riskier Less costly alternative Non-drug treatment 3. Simplify Dosing schedule Substitute one drug for two 32 October 10,
17 Simplified Geriatric Dosing From The New Yorker, November, October 10, Kaiser Foundation Health Plan, Inc. For internal use only. Med Reconciliation and Polypharmacy Omissions OTCs/ Herbals Side Effects Duplication Correct Dose Cost Effective Renal Dose Adjustments Med Rec Drugs to Avoid in the Elderly Drug-Drug Interactions Is drug still appropriate? Correct Directions Unclear Orders Drug-Disease Interactions Indication Adherence Hajjar ER, Calfiero AC, Hanlon JT. Polypharmacy in Elderly Patients. Am J of Geriatric Pharmacother 2007; 5(4); Kaiser Permanente All Rights Reserved. 34 October 10,
18 Inside KP Inside KP KPCO publishes polypharmacy intranet page KPGA addresses too-low HGBA1C and non-benzo sedatives KPNW s med rec aims to reduce polypharmacy DUM (Drug Utilization Management) program reverses trend in opioid prescribing MTM (Medication Therapy Management) stops unnecessary meds 35 October 10, 2016 MTM and Comprehensive Medication Review at KP Associated with - Lowered mortality - Less hospitalization Rita L. Hui, PharmD, MS; Brian D. Yamada, PharmD; Michele M. Spence, PhD; Erwin W. Jeong, PharmD; and James Chan, PharmD, PhD. Impact of a Medicare MTM Program: Evaluating Clinical and Economic Outcomes. Am J Manag Care. 2014;20(2):e43-e51 18
19 4. Signs of the deprescribing era Beers list, Choosing Wisely, Direct-to-consumer media efforts More published medical literature, algorithms CMMS incentives A cultural shift O Mahony D, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44: JethaS. Polypharmacy, the Elderly, and Deprescribing. The Consultant Pharmacist. September, 2015;30(9): October 10, Beers List Criteria Update 1991 Criteria originated by Mark Beers 2011 AGS (Am Geriatrics Society) charged with review and updates 2015 Revision 1 Alternatives proposed 2 Serious Drug-Drug interactions itemized Drugs requiring renal failure dosing are listed Shifts in emphasis result from literature review 1 DOI: /jgs JAGS, October DOI: /jgs October 10,
20 Polypharmacy in preventive cardiology 1 Problem: Millions on CVD drugs* though proof of benefit lacking. Short-term study results are extrapolated over decades. Results from young-old subjects are extrapolated to old-old. We have scant evidence on outcomes of drug withdrawals. Modern clinical practice differs from that when trials were conducted.. Projections of benefits assume hazards are constant over time. Old-old adults may prefer different outcomes. * Aspirin, beta-blockers, statins, ACE inhibitors How long should these drugs be continued? 1 J Am Coll Cardiol 2015;66: October 10, Benefits of Deprescribing Simplify care Reduce ADEs Reduce hospitalization Improve adherence Reduce costs Save lives 40 October 10,
21 Declining opioid use in KP 12/13 to 6/15 Case History Discussion yo on opioids for chronic pancreatitis reports unexpected death of his spouse yo retired math teacher with dementia becomes a zombie after entering a NH yo female diabetic in ED for falls has HGBA1C of 6%. 4. Wife says her 79 yo won t take all his medicines. 42 October 10,
22 Bibliography InsidePatientCare.com Empowering Community Pharmacists as Health Consultants: Polypharmacyby Rebecca J. Mahan, PHARMD, CGP Brisbane, et al. Reducing Inappropriate Polypharmacy. JAMA Intern Med. doi: /jamainternmed Tjia, et al. Use of Medications of Questionable Benefit JAMA Intern Med. 2014;174(11): doi: / jamainternmed GarfinkleD, ManginD. Feasibility of a systemic approach Arch Intern Med. 2010;170(18): BMJ 2012:345:e6617 Overtreatment Is the USA s problem ours too? BMJ 2012;345:e668 Overtreamentover here. Lam MP1, Cheung BM. The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Rev Clin Pharmacol2012;5: (STOPP/START criteria) PL Detail-Document, STARTingand STOPPingMedications in the Elderly. Pharmacist s Letter/Prescriber s Letter. September (STOPP/START criteria) Frankenthal, et al. Intervention with the Screening Tool of Older Persons Potentially Inappropriate Prescriptions/Screening Tool to Alert Doctors to Right Treatment Criteria in Elderly Residents of a Chronic Geriatric Facility: A Randomized Clinical Trial. J Am Geriatr Soc 62: , Grounder, Celiine. Who is responsible for the pain-pill epidemic? The New Yorker, November 8, MoonenJ et al. Effect of Discontinuing JAMA Intern Med. doi: /jamainternmed Published online August 24, OddenMC. (Editorial) JAMA Intern Med. Published online August 24, doi: /jamainternmed Beers Criteria Update: DOI: /jgs and alternatives: DOI: /jgs Jetha S. Polypharmacy, the Elderly, and Deprescribing. The Consultant Pharmacist. September, 2015;30(9): RochonP, GurwitzJ. Optimisingdrug treatment for elderly people: the prescribing cascade. BMJ, 1997; 315: QatoDM, et al. Changes in Prescription and Over-the-Counter Medication JAMA Intern Med. Published online March 21, doi: /jamainternmed BemdenMN.Deprescribing: An Application to Medication Management in Older Adults. Pharmacotherapy 2016;36(7): ) doi: /phar.1776 Tools and collaborators nes&sdtype=clinical&location=adultcare&memberage=adult%20care&cntname=polypharmacy%20in%20the%20elderly How to deprescribe (1) ascertain all drugs the patient is currently taking and the reasons for each one (2) consider overall risk of drug-induced harm in individual patients in determining the required intensity of deprescribingintervention (3) assess each drug in regard to its current or future benefit potential compared with current or future harm or burden potential (4) prioritize drugs for discontinuation that have the lowest benefit-harm ratio and lowest likelihood of adverse withdrawal reactions or disease rebound syndromes (5) implement a discontinuation regimen and monitor patients closely for improvement in outcomes or onset of adverse effects. JAMA Intern Med. doi: /jamainternmed
Deprescribing Unnecessary Medications: A Four-Part Process
Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient
More informationThank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016
Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements
More informationPolypharmacy & De-prescribing In Older Adults
Polypharmacy & De-prescribing In Older Adults Maryland Association of Osteopathic Physicians Annual Meeting September 15, 2018 Elizabeth Phung, DO Lead Clinical Associate Physician Beacham Center for Geriatric
More informationPolypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics
Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse
More informationShared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes
Shared decision making for stepdown and stopping decisions Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes 1 Disclosures I have had travel and lodging paid for
More informationDavid Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy
David Gardner, BSc Pharm, MSc CH&E, PharmD Professor, Department of Psychiatry & College of Pharmacy It s no dream. Sleep well without sleeping pills. Outline Baby boomers & beyond: medication use Deprescribing
More informationDisclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.
The elderly at risk: reducing medications safely to meet life s changes Barbara Farrell BScPhm, PharmD, FCSHP European Society of Hospital Pharmacists Conference March 2017 Disclosure Relevant financial
More informationMurthy Gokula MD,CMD
Murthy Gokula MD,CMD MEDICATIONS & LIFE EXPECTANCY DON T ROUTINELY PRESCRIBE LIPID-LOWERING MEDICATIONS IN INDIVIDUALS WITH A LIMITED LIFE EXPECTANCY: AAHPM About Choosing Wisely First conceived by the
More informationAbout ISMP Canada. Analysis Outputs: Safety Bulletins. Less is More: An Introduction to Deprescribing. canada.org
Less is More: An Introduction to Deprescribing Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About ISMP Canada The Institute for Safe Medication Practices Canada
More informationStrategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS
Strategies to Decrease Medication Errors in Elderly Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS Road Map..Outline 1. Introduction A. Definitions B. Geriatrics: High risk population C.
More informationTransforming Care for the Elderly
Transforming Care for the Elderly Session 2: Engaging Pharmacists & Interdisciplinary Care Teams to Improve Prescribing of Antipsychotics & to Reduce Polypharmacy January 11, 2017 3 @cfhi_fcass Welcome
More informationOutcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians
Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians Executive summary Australia has a significant opportunity to improve the quality use
More information4/26/2016 DISCLOSURES BACKGROUND OBJECTIVES BACKGROUND BACKGROUND
http://thinkprogress.org/health/01/10//1061/how-rising-health-care-costs-impact-the-national-budget/ http://www.firstaidforfree.com/wp-content/uploads/015/09/falls.jpg http://drwills.com/wp-content/uploads/015/05/drugcycle.jpg
More informationThere s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients
There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor
More informationLess is More: Introduction to Deprescribing
Less is More: Introduction to Deprescribing 7th Annual Pharmaceutical Care Conference Muscat, Oman Feb 23, 2017 Lindsay Yoo, BSc, BScPhm, RPh, CDE, CGP, PharmD Medication Safety Analyst, ISMP Canada About
More informationPresented by: Ontario s Geriatric Steering Committee
Polypharmacy: A Medication Management Opportunity Chris Fan-Lun, BScPhm, ACPR, CGP Clinical Practice Leader, Dept. of Pharmacy Services Mount Sinai Hospital, Sinai Health system Learning Objectives Provide
More informationThe Opioid Crisis in Kentucky. Doug Oyler, PharmD Director, Office of Opioid Safety UK HealthCare
The Opioid Crisis in Kentucky Doug Oyler, PharmD Director, Office of Opioid Safety UK HealthCare Discuss the role of opioid prescribing in creating and sustaining the crisis Describe components and initiatives
More informationGeriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More informationHHS Public Access Author manuscript Int J Clin Pharm. Author manuscript; available in PMC 2016 October 01.
Recommendations to support deprescribing medications late in life Adam Todd 1 and Holly M. Holmes 2 1 Division of Pharmacy, School of Medicine, Pharmacy and Health, Durham University, Queen s Campus, Stockton-on-Tees,
More informationTools for Targeting High Risk Patients in Your Practice. Statement of Disclosure
Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School
More informationPolymedication in nursing home. Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy
Polymedication in nursing home Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy Services and Health for Elderly in Long TERm care (SHELTER) 4156 residents
More informationOptimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014
Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed
More informationPOLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE
POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of
More informationIan Scott. Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital
National Workshop in Deprescribing Setting the scene Ian Scott Director of Internal Medicine and Clinical Epidemiology Princess Alexandra Hospital Associate Professor of Medicine University of Queensland
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationAkinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5),
Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), 268-271 Copyright: This is an Accepted Manuscript of an article published by Taylor
More informationUpdate in Geriatrics: Choosing Wisely Primum Non Nocere
Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor
More informationSAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND. Sandra Brownstein, PharmD, CGP
SAFETY CONCERNS WITH MULTIPLE MEDICATIONS AND BEYOND Sandra Brownstein, PharmD, CGP Objectives: List potential medication related problems that increase in the frail elderly with acute illness Differentiate
More informationRationalizing Medications. Tan Jianming Senior Pharmacist KTPH
Rationalizing Medications Tan Jianming Senior Pharmacist KTPH + Older patients are more likely to: 2 Have multiple co-morbid diseases Have age-related physiological changes that result in a reduced tolerance
More information3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata
More informationInnovative Opportunities for Pharmacists in the Evolving World of Healthcare
Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical
More information9/11/2012. Clare I. Hays, MD, CMD
Clare I. Hays, MD, CMD Review regulatory background for current CMS emphasis on antipsychotics Understand the risks and (limited) benefits of antipsychotic medications Review non-pharmacologic management
More informationAppropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board
Appropriate prescribing and deprescribing for older people getting it right Alan Davis Northland District Health Board Unused returns Potentially inappropriate medication use in the elderly 15% of older
More informationPolypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD
Polypharmacy and the Older Adult Leslie Baker, PharmD, BCGP Umanga Sharma, MD Objectives Identify what polypharmacy is Identify factors leading to polypharmacy Discuss consequences of polypharmacy Identify
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationSession Objectives 11/27/2013
Workshop A3 and B3 This presenter has nothing to disclose Clinical and Cost Improvement for Population Health Scott Weingarten, MD Senior Vice President and Chief Clinical Transformation Officer Cedars-Sinai
More informationSeptember 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic
National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership
More informationAnthony J. Caprio, MD, CMD, AGSF 1
Objectives 1) Discuss the dangers of polypharmacy 2) Review potentially inappropriate medications for older adults Doc, I think I am taking too many medications! 3) Develop strategies for prioritizing
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationPolypharmacy and Deprescribing for Older People
Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University
More informationENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS
ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent
More informationMedication Management. Medications: The Right Balance. Who are we talking about? Geriatric Syndromes 9/19/2016. Older adults are a heterogenous group!
Medication Management Who are we talking about? Older adults are a heterogenous group! Patricia W. Slattum, PharmD, PhD Professor of Pharmacotherapy and Outcomes Science Director, Geriatric Pharmacotherapy
More informationIdentifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP JUNE 9, 2017
Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP LEARN@LUNCH JUNE 9, 2017 Objectives of Talk Identify inappropriate medications in a medication regimen
More informationIf a bad thing is happening to a patient, a drug did it until proven otherwise
Dr Vicki s First Rule of Geriatrics Deprescribing in the Elderly Victoria Braund MD, FACP, CMD Director, Division of Geriatrics NorthShore University HealthSystem Medical Director, Brandel Health & Rehab
More informationBriefing Document on Medication use and Falls
Briefing Document on Medication use and Falls This document is intended as a briefing document and is not to be regarded as a document offering definitive legal advice in relation to the subject matter.
More informationMedications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy
Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion
More informationMaximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016
Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day
More informationThe Role of Pharmacists achieving international best practice standards and realising key opportunities.
The Role of Pharmacists achieving international best practice standards and realising key opportunities. Dr. Stephen Byrne Senior Lecturer in Clinical Pharmacy & Director of the MSc in Clinical Pharmacy
More informationPolypharmacy and Polymorbid Patients: Practical Tips and Tricks
Polypharmacy and Polymorbid Patients: Practical Tips and Tricks November 2, 2013 Faculty/Presenter Disclosure Faculty: Chris Fan-Lun, BScPhm, ACPR, CGP Pharmacist - Geriatric Medicine Clinical Practice
More informationDavid Bienenfeld, M.D. Wright State University Department of Psychiatry
David Bienenfeld, M.D. Wright State University Department of Psychiatry 1 Describe the epidemiologic patterns of substance abuse over age and time List the metabolic changes that influence the effect of
More informationLe politerapie complesse: l'arte del deprescribing. Andrea Corsonello IRCCS INRCA - Cosenza
Le politerapie complesse: l'arte del deprescribing Andrea Corsonello IRCCS INRCA - Cosenza Archibald Leman Cochrane (12 January 1909 18 June 1988) was a Scottish doctor noted for his book Effectiveness
More informationA Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine
A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation
More informationCost-Effective Process to Improve Drug Adherence for Medicare 5-Star
Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating
More informationPatient Safety in Older Adults
Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical
More informationHospital Transition Management. Barbara Wood, BSN, MBA
Hospital Transition Management Barbara Wood, BSN, MBA Director, Embedded Care Management Programs OBJECTIVES Improve health care quality for our patients by streamlining care transitions Reduce avoidable
More informationDavid Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care
David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care Geriatrics Clinic- Providence VAMC VA Grand Rounds
More informationRebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L.
Rebecca Rottman-Sagebiel, Pharm.D., BCPS Sharon Jung Tschirhart, Pharm.D., BCPS Geriatric Clinical Pharmacy Specialists STVHCS, Audie L. Murphy Division Clinical Assistant Professors, University of Texas/UTHSCSA
More informationDeprescribing: A Practical Guide
Deprescribing: A Practical Guide The information in this booklet should be used as a pragmatic decision aid, in conjunction with other relevant patient specific data. Useful resource links http://www.derbyshiremedicinesmanagement.nhs.uk/assets/clinical_guidelines/clinical_guidelines_fr
More informationPatient Safety in Older Adults
Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical
More informationAN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES
AN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES Elizabeth (Betsy) Crowe, PhD Lucille J. Carriere, PhD Objectives
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationOPIOID CRISIS: A PERSPECTIVE. Karl J. Haake, MD
OPIOID CRISIS: A PERSPECTIVE Karl J. Haake, MD LEARNING OBJECTIVES Summarize the history behind the opioid epidemic in America Identify the issues surrounding the the treatment of chronic pain Demonstrate
More information2/11/2016. Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals. Disclosure. Objectives
Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals Heather Veeder MD Medical Director VITAS Healthcare San Antonio, TX Adjunct Professor of Medicine University of Texas Health Science
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More information61 Recommendations for better use of medications
Chapter 61 Recommendations for better use of medications As stated elsewhere in this book, we are fortunate to have a number of effective medications for treatment of many medical conditions. The drug
More informationThe Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division
The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able
More informationMeds and Falls: Keep in Step with your Meds
Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu
More informationAmal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region
Risks Of Polypharmacy Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region What is Polypharmacy? Polypharmacy means many drugs. In practice, polypharmacy refers to the use of more medication
More informationOur Core Thoughts on Dealing with the Opioid Addiction Crisis. Meghan McNelly, PharmD, MHA, FACHE Suzette Song, MD Joseph Alhadeff, MD
Our Core Thoughts on Dealing with the Opioid Addiction Crisis Meghan McNelly, PharmD, MHA, FACHE Suzette Song, MD Joseph Alhadeff, MD Outline Brief History of the Opioid Problem How did we as a medical
More informationChoosing Wisely Campaign. Lynn McNicoll, MD Alpert Medical School of Brown University Division of Geriatrics and Palliative Medicine
Choosing Wisely Campaign Lynn McNicoll, MD Alpert Medical School of Brown University Division of Geriatrics and Palliative Medicine Disclosures None Purpose of Campaign 5 items (tests, medications, procedures)
More informationUpdate in Outpatient Medicine ACP Scientific Session November 12, 2016
Update in Outpatient Medicine ACP Scientific Session November 12, 2016 Robert Gluckman MD, MACP Chief Medical Officer Providence Health Plans Disclosures Stock Holdings Abbott Labs Abbvie Bristol Myers
More informationOregon Opioid Prescribing Guidelines
Oregon Opioid Prescribing Guidelines Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Jim Rickards, MD, MBA Chief Medical Officer Oregon Health Authority Personal
More informationNew Guidelines for Opioid Prescribing
New Guidelines for Opioid Prescribing What They Mean for Elders with Chronic Pain Manu Thakral, PhD, ARNP Kaiser Permanente Washington Health Research Institute Kaiser Permanente Washington Health Research
More informationCase Study #1 GUIDING PRINCIPLES FOR THE CARE OF OLDER ADULTS WITH MULTIMORBIDITY
Case Study #1 GUIDING PRINCIPLES FOR THE CARE OF OLDER ADULTS WITH MULTIMORBIDITY Panel Moderator & Panelists: Edward Perrin, MD Banner icare Scott Bolhack, MD, MBA Sandra Brownstein, PharmD Paige Hector,
More information4/3/2018. C-MEDS: An Innovative Community Medication Safety Program for Seniors & Caregivers. Objectives. Background: Aging & Medication
C-MEDS: An Innovative Community Medication Safety Program for Seniors & Caregivers Marsha Meyer, PharmD, BCGP, CGCM Director, Independence at Home, a SCAN community service Objectives At the conclusion
More informationOptimizing medication in caring for seniors living with frailty: Five perspectives
Optimizing medication in caring for seniors living with frailty: Five perspectives Community Care Shanna Trenaman BScH, BScPharm, MAHSR, ACPR, PhD(student) Project Manager for A Collaborative Intervention
More informationFall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)
Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who
More informationBLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative
BLCS 1-Clinical Overview Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative Fraser Health Guide To Person-Centered Medication Decisions Factors to Consider When Systematically
More informationIMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING. Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz
IMPROVING MEDICATION SAFETY AMONG ELDERLY PATIENTS IN AN AMBULATORY SETTING Alyssa Berry, Rebecca Burgett, Erin Day, Aron Hrubetz Improving Medication Safety Among Elderly Patients in an Ambulatory Setting
More informationPA LTC Pharmacist s Role in Patient Safety and De-Prescribing
PA LTC Pharmacist s Role in Patient Safety and De-Prescribing Nicole J. Brandt, PharmD, MBA, CGP, BCPP, FASCP Professor, Geriatric Pharmacotherapy, Pharmacy Practice and Science UMB School of Pharmacy
More informationPolypharmacy. A CPPE distance learning programme
A CPPE distance learning programme DLP 177 January 2016 Contents About CPPE distance learning programmes About this learning programme Glossary of key terms v vii ix Contents Section 1 The problem with
More informationPOLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group
POLYPHARMACY A practical approach to deprescribing in care homes. Care Home Pharmacy Team Herts Valleys Clinical Commissioning Group Neeta Gulhane Specialist Pharmaceutical Advisor Care Homes The Care
More informationAN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE
AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE Valerie Carrejo, MD Assistant Professor UNM Family Medicine Advances in Primary Care April 14, 2017 Objectives Review the basic
More informationTargeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy
Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy Presentation Objectives Discuss Polypharmacy In HD patients Define Deprescribing Review results of the pilot study on deprescribing
More informationReview of Current Literature 4/2/18 POLYPHARMACY IN ASSISTED LIVING EVIDENCE BASED APPROACH
POLYPHARMACY IN ASSISTED LIVING A Evidence Based Approach to Management of Medication Regimen Complexity By Burton Korer, MSN, RN-BC, CPHQ EVIDENCE BASED APPROACH Evidence-based practice (EBP) is the conscientious
More informationThe Impact of Opioid Use and Abuse on Medical Community, Businesses, Social Organizations and Individiuals and Their Families
The Impact of Opioid Use and Abuse on Medical Community, Businesses, Social Organizations and Individiuals and Their Families THE MAGNITUDE OF THE OPIOID EPIDEMIC THE COSTS TO LOCAL, STATE AND NATIONAL
More informationPolypharmacy in HIV and Aging. Aroonsiri Sangarlangkarn, MD, MPH, Jonathan S. Appelbaum, MD, FACP
Polypharmacy in HIV and Aging Aroonsiri Sangarlangkarn, MD, MPH, Jonathan S. Appelbaum, MD, FACP Educational Objectives By the end of the session, learners will be able to: 1. Describe one feature that
More informationDrug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome
Drug use in long term care Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome Polypharmacy in nursing home (USA) Concurrent use of 9 medications was reported for 39.7%
More informationEvidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia
Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia ADI 2018, Chicago FACULTY OF MEDICINE Dr Emily Reeve NHMRC Cognitive Decline
More information< = > less is more. De-diagnosing De-prescribing Non-testing
< = > less is more De-diagnosing De-prescribing Non-testing Who says? Overdiagnosis Polypharmacy False positives Too much medicine Risk aversion $$$ Sources Prof David Le Couteur, Clin Pharm and Aged Care
More informationMail Order Is Not For Everyone!
Mail Order Is Not For Everyone! Face to face patient counseling by pharmacists can have a powerful impact on long term health care costs and quality. So, the way health plan sponsors promote mail and generics
More informationOPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN
OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN ANTOINETTE BROWN, RPH LAUREL RAMER, 2019 PHARMD CANDIDATE 2018 WYOMING CONFERENCE ON AGING LARAMIE, WY OCTOBER 3, 2018 OBJECTIVES 1. Understand the
More informationSafe Prescribing of Drugs with Potential for Misuse/Diversion
College of Physicians and Surgeons of British Columbia Safe Prescribing of Drugs with Potential for Misuse/Diversion Preamble This document establishes both professional standards as well as guidelines
More informationMedications are Additive (Anticholinergic) Diane W. Healey, M.D. Center for Healthy Aging March 10, 2017
Medications are Additive (Anticholinergic) Diane W. Healey, M.D. Center for Healthy Aging March 10, 2017 Disclosures This speaker has indicated there are no relevant financial relationships to be disclosed.
More informationEMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE
More informationMEDICATION APPROPRIATENESS FOR THE AGING POPULATION. Building Partnerships for Successful Aging
MEDICATION APPROPRIATENESS FOR THE AGING POPULATION Building Partnerships for Successful Aging Learning objectives Appreciate complexities involved in making appropriate clinical decisions in older adults
More informationHow to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy
How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy Presented by: Dale Christensen, University of North Carolina Susmita Chavala, Humana Ed Staffa, Community MTM
More informationSTART, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy
START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment
More information